We are live on ! Find out more
EVH icon

Evolent Health

218 hedge funds and large institutions have $2.78B invested in Evolent Health in 2022 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 87 increasing their positions, 75 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 24

42% more call options, than puts

Call options by funds: $9.86M | Put options by funds: $6.97M

19% more capital invested

Capital invested by funds: $2.34B → $2.78B (+$437M)

16% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 75

5% more funds holding

Funds holding: 207218 (+11)

0.53% more ownership

Funds ownership: 94.74%95.26% (+0.53%)

13% less funds holding in top 10

Funds holding in top 10: 87 (-1)

Holders
218
Holders Change
+11
Holders Change %
+5.31%
% of All Funds
3.44%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
37
Increased
87
Reduced
75
Closed
24
Calls
$9.86M
Puts
$6.97M
Net Calls
+$2.9M
Net Calls Change
-$8.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$247M +$2.93M +111,882 +1%
EC
2
Engaged Capital
California
$231M -$17.9M -683,297 -9%
BlackRock
3
BlackRock
New York
$200M +$7.62M +291,029 +5%
JP Morgan Chase
4
JP Morgan Chase
New York
$198M +$1M +38,364 +0.6%
GIM
5
Granahan Investment Management
Massachusetts
$146M -$12.4M -471,920 -9%
Fidelity Investments
6
Fidelity Investments
Massachusetts
$111M -$18.9M -720,733 -17%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$103M -$2.68M -102,416 -3%
CS
8
Credit Suisse
Switzerland
$92.8M -$765K -29,204 -1%
BG
9
Bellevue Group
Switzerland
$84.4M +$77.8K +2,970 +0.1%
FAM
10
Fred Alger Management
New York
$81.7M +$1.97M +75,282 +3%
Loomis, Sayles & Company
11
Loomis, Sayles & Company
Massachusetts
$81.6M +$14.3M +544,667 +27%
RSCM
12
Rock Springs Capital Management
Maryland
$76.9M +$8.95M +342,000 +17%
William Blair & Company
13
William Blair & Company
Illinois
$76.5M -$2.96M -112,959 -5%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$60.7M -$653K -24,945 -1%
State Street
15
State Street
Massachusetts
$53.5M +$1.94M +74,019 +5%
Point72 Asset Management
16
Point72 Asset Management
Connecticut
$45.8M +$25.9M +989,701 +232%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$45.3M +$1.8M +68,707 +5%
O
18
OrbiMed
New York
$45.2M +$12.1M +462,000 +49%
GF
19
Greenhouse Funds
Maryland
$42.8M +$3.37M +128,859 +11%
Citadel Advisors
20
Citadel Advisors
Florida
$34.3M +$20.4M +778,289 +276%
N
21
Nuveen
North Carolina
$31.1M +$646K +24,664 +3%
EAM
22
Eagle Asset Management
Florida
$31M -$21.3M -813,083 -46%
Northern Trust
23
Northern Trust
Illinois
$30.9M -$999K -38,151 -4%
GT
24
Glenmede Trust
Pennsylvania
$29.7M -$243K -9,295 -1%
Millennium Management
25
Millennium Management
New York
$29.1M +$15.2M +582,257 +183%

EVH Hedge Fund Activity: Q1 2022 in Review

218 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2022, worth a combined $2.78B — up 19% from $2.34B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new EVH positions and 24 closed out — a net gain of 13 holders — while 87 added to existing stakes and 75 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $25.9M. The largest seller was Great Lakes Advisors, exiting entirely with an estimated $21.8M sold.

  • 218 institutional investors held Evolent Health (EVH) as of Q1 2022, up from 207 in Q4 2021.
  • Funds reported $2.78B of Evolent Health stock for Q1 2022, up 19% quarter-over-quarter.
  • 37 funds opened new Evolent Health positions in Q1 2022 and 24 closed out, a net change of +13 holders.
  • The largest Evolent Health buyer in Q1 2022 was Point72 Asset Management, an estimated $25.9M added.
  • The largest Evolent Health seller in Q1 2022 was Great Lakes Advisors, an estimated $21.8M sold.

Based on aggregated 13F filings for Q1 2022.